US plans Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports
GLP-1 drugs have gained popularity for their ability to reduce body weight by suppressing appetite and slowing digestion.
WASHINGTON - The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Aug 1, citing documents from the Centers for Medicare and Medicaid Services.
GLP-1 drugs, originally developed for type 2 diabetes, have gained popularity for their ability to reduce body weight by suppressing appetite and slowing digestion. But their high cost – typically between US$5,000 (S$6,490) and US$7,000 per year – has raised concerns about long-term affordability.
The proposed plan would permit state Medicaid programs and Medicare Part D insurance plans to voluntarily cover GLP-1 drugs, including those from market leaders Novo Nordisk and Eli Lilly, the report said.
Lilly and Novo are leaders in the weight-loss drug market, which some analysts expect could bring in more than US$150 billion in revenues by the next decade. Lilly's shares were up nearly 2 per cent in premarket trading.
The initiative is slated to begin in April 2026 for Medicaid and January 2027 for Medicare. If it clears the way, it would mark a shift in federal policy after the administration said earlier this year that the programs would not cover weight loss drugs.
A proposal under the Biden administration had also aimed to expand access to the medications.
The Centres for Medicare & Medicaid Services, Lilly and Novo did not immediately respond to a Reuters request for comment. REUTERS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
an hour ago
- Straits Times
Nearly 12,000 children under five in Gaza have acute malnutrition, says WHO
Sign up now: Get ST's newsletters delivered to your inbox Some 2,500 of those children are suffering from severe malnutrition. GENEVA - Around 12,000 children aged under five in Gaza are suffering from acute malnutrition, and hunger-related deaths are rising, the director-general of the World Health Organisation said on Aug 7. "In July, nearly 12,000 children under five years were identified as having acute malnutrition in Gaza, the highest monthly figure ever recorded," Dr Tedros Adhanom Ghebreyesus said at his organisation's headquarters in Geneva. At least 99 people have died, including 64 adults and 35 children, of whom 29 were younger than five, from the start of 2025 to July 29. Between June and July, the number of admissions for malnutrition almost doubled – from 6,344 to 11,877 – according to the latest Unicef figures available. Some 2,500 of those children are suffering from severe malnutrition. Dr Tedros called for greater volumes of sustained aid, via all possible routes. The WHO said it was supporting Gaza's four malnutrition centres, but that supplies of baby formula and nutritional foods were very low. Top stories Swipe. Select. Stay informed. Singapore Liquor licences for F&B, nightlife venues extended to 4am in Boat Quay, Clarke Quay Singapore Chikungunya cases in Singapore double; authorities monitoring situation closely Singapore Student found with vape taken to hospital after behaving aggressively in school; HSA investigating Asia Cambodia, Thailand agree on Asean observers monitoring truce, but fundamental differences remain Singapore CDC and SG60 vouchers listed on e-commerce platforms will be taken down: CDCs Asia Australia's purchase of Japanese frigates signals a new era for Indo-Pacific security Singapore Jail for driver who drove over leg of special needs woman in accident on church driveway Singapore Some ageing condos in Singapore struggle with failing infrastructure, inadequate sinking funds "The overall volume of nutrition supplies remains completely insufficient to prevent further deterioration. The market needs to be flooded. There needs to be dietary diversity," said Dr Rik Peeperkorn, WHO's representative for the occupied Palestinian Territory, via video link. A global hunger monitor has said a famine scenario is unfolding in the Gaza Strip, with starvation spreading, children dying of hunger-related causes and humanitarian access to the embattled enclave severely restricted. The United Nations Office for the Coordination of Humanitarian Affairs (OCHA) said food consumption across Gaza had declined to its lowest level since the onset of the war. Eighty-one per cent of households in the tiny, crowded coastal territory of 2.2 million people reported poor food consumption, up from 33 per cent in April. REUTERS
Straits Times
3 hours ago
- Straits Times
Innovative customised procedure can help to prevent aortic aneurysms
Sign up now: Get ST's newsletters delivered to your inbox Adjunct Associate Professor Vitaly A. Sorokin (left) and Adjunct Associate Professor Low Ting Ting with Mr Long Foo Pieng, who was among the first few patients to undergo the procedure. SINGAPORE - Aortic aneurysms – where the aorta, the largest artery in the human body, swells to more than 1½ times its normal size – is estimated to result in up to 200,000 deaths worldwide annually. In cases of aortic rupture, when all the layers of the aorta wall tear, there is an 80 per cent mortality rate. An innovative surgical procedure , now available in Singapore, can stop an aneurysm from growing and prevent an aortic rupture from happening. Originating from the heart's left ventricle, the aorta is the body's main artery, directing oxygenated blood from the heart to the rest of the body. An aortic aneurysm can be caused by many factors, such as high blood pressure, genetic conditions or aortic valve issues. The condition is often under-diagnosed, thus increasing the risk that the bulge in the aorta continues to grow and eventually ruptures along the elastic wall, resulting in rapid, life-threatening blood loss. To reduce the risk of such an occurrence, the National University Heart Centre, Singapore (NUHCS) has introduced a procedure called the Personalised External Aortic Root Support (Pears), which uses a custom-made, open mesh support sleeve to reinforce a weakened aorta. Top stories Swipe. Select. Stay informed. Singapore Liquor licences for F&B, nightlife venues extended to 4am in Boat Quay, Clarke Quay Singapore Chikungunya cases in Singapore double; authorities monitoring situation closely Singapore Some ageing condos in Singapore struggle with failing infrastructure, inadequate sinking funds Singapore CDC, SG60 vouchers listed on e-commerce platforms will be taken down: CDC Singapore Jail for driver who drove over leg of special needs woman in accident on church driveway Asia Australia's purchase of Japanese frigates signals a new era for Indo-Pacific security Singapore Wastewater overflow in Bedok and Chai Chee due to choked sewer at BTO worksite: PUB Singapore Ex-Hyflux director fined over firm's failure to disclose Tuaspring info When applied at the earlier stages of an aneurysm before the aorta has grown too large, Pears acts as a protective 'glove' around the artery, preventing further expansion and significantly reducing the risk of a rupture. 'The open-mesh sleeve used to support the weakened aorta in Pears is custom-shaped to a 3D-printed model of a patient's aorta from their CT scan,' said Adjunct Associate Professor Vitaly A. Sorokin, who heads the adult cardiac surgery division at NUHCS' cardiac, thoracic and vascular surgery department. 'Due to the customised nature of this sleeve, it provides personalised long-term structural support to the heart vessel, which is crucial in stopping the aneurysm from growing larger,' he added. Pears is developed by British medical manufacturing firm Exstent, whose founder, Mr Tal Golesworthy, has Marfan syndrome – a genetic disorder that affects the body's connective tissue and can weaken the aorta's walls. An engineer by training, Mr Golesworthy designed Pears as a solution to treat his own aorta, becoming the first person to have the device implanted in 2004. Though the procedure has been around for more than two decades, it has only become more widely adopted internationally over the past 10 years, amid advancements in CT scanning and 3D printing, said Prof Vitaly. NUHCS is believed to be the first centre to introduce Pears in South-east Asia, first performing the procedure in November 2024. Six patients, aged between 40 and 55, have undergone the procedure since it was introduced, all of whom are faring well. Among the first few patients to undergo the procedure was 56-year-old Long Foo Pieng, who in 2004 was diagnosed with congenital bicuspid aortic valve – a heart defect present at birth, where the aortic valve has only two leaflets instead of three. This can result in aortic stenosis, where the valve narrows, or aortic regurgitation, where the blood flows backwards from the aorta into the left ventricle. These conditions can be fatal if severe and left untreated. The retired company director initially managed the condition using medication and lifestyle adjustments, as surgery would require that the valve be replaced with a prosthetic substitute, which would require significant changes to his lifestyle, said Adjunct Associate Professor Low Ting Ting, a senior consultant with the cardiology department. However, his condition eventually led to aortic dilation, requiring surgery. 'When this Pears procedure came along, it allows us to manage to constrict the size of his aorta without replacing the aortic valve,' said Prof Low. After undergoing Pears, Mr Long was discharged from the hospital within a week. He recovered well and in six months was able to resume his normal day-to-day activities. 'I was very happy back at the golf course again, going to the driving range almost two to three times a week,' he said.
Straits Times
4 hours ago
- Straits Times
Chikungunya cases in Singapore double; authorities monitoring situation closely
Sign up now: Get ST's newsletters delivered to your inbox Chikungunya is rarely fatal, but it does cause fever and severe joint pain. SINGAPORE – There has been a spike in the number of chikungunya cases in Singapore in the past few months, with the authorities closely monitoring the situation amid global concern over the mosquito-borne virus. There were 17 cases of chikungunya fever in Singapore as at Aug 2, according to the Communicable Diseases Agency's (CDA) infectious disease bulletin published on Aug 7. This is more than double the eight registered in the same period in 2024. The total number of cases for 2024 was 15. Of the cases reported so far in 2025, at least 13 recently travelled to affected areas overseas while at least three local cases are not linked to one another, said CDA in response to queries from The Straits Times. There were initially two cases in February, gradually increasing at about two cases a month until there were nine by the end of May. However, the number jumped to 13 in June and then to 16 in July. CDA said if new information surfaces that suggest the virus poses an increased risk in Singapore, it will review the need for additional public health measures. Chikungunya, transmitted by the bites of infected mosquitoes, is rarely fatal, but it does cause fever, severe joint pain and long-term disability. It has no specific treatment. Top stories Swipe. Select. Stay informed. Singapore Liquor licences for F&B, nightlife venues extended to 4am in Boat Quay, Clarke Quay Singapore Some ageing condos in Singapore struggle with failing infrastructure, inadequate sinking funds Singapore CDC, SG60 vouchers listed on e-commerce platforms will be taken down: CDC Singapore Jail for driver who drove over leg of special needs woman in accident on church driveway Asia Australia's purchase of Japanese frigates signals a new era for Indo-Pacific security Singapore Wastewater overflow in Bedok and Chai Chee due to choked sewer at BTO worksite: PUB Singapore Ex-Hyflux director fined over firm's failure to disclose Tuaspring info In July, the World Health Organisation issued an urgent call for action to prevent a repeat of a chikungunya epidemic that swept the globe two decades ago. It affected nearly half a million people from 2004 to 2005, primarily in small island territories, before spreading around the world. The current surge began in early 2025, with major outbreaks in the same Indian Ocean islands that were previously hit, including La Reunion, Mayotte and Mauritius. Over the past four weeks, about 8,000 people in China have been infected, mostly in Foshan. The outbreak is the country's largest of its kind since the virus first emerged in China in 2008. A spokesperson for the US Centres for Disease Control and Prevention said on July 31 that it was planning to issue a travel notice for China as chikungunya infections rose there. Singapore is at risk of chikungunya transmission due to the presence of the Aedes mosquito in the country, alongside importation of the virus by travellers, said CDA. 'Outbreaks of chikungunya are rising in the Americas, Asia and Europe in 2025. Those living in temperate countries, who were not affected by mosquito-borne diseases in the past, now face increased risk due to climate change,' it added. CDA advises the public to remain vigilant and continue doing their part to prevent mosquito breeding in homes and workplaces. Individuals, especially those travelling to chikungunya-affected areas, should take precaution against mosquito bites by applying effective insect repellent, wearing long, protective clothing, or staying in rooms with screening to prevent insects from entering, said CDA. Travellers who become unwell should seek medical attention promptly and inform the doctor of their travel history and any mosquito bites. They should also use an effective insect repellent to prevent infecting mosquitoes which can then spread the disease to others, CDA added.
